Copyright
©The Author(s) 2021.
World J Hepatol. Oct 27, 2021; 13(10): 1439-1449
Published online Oct 27, 2021. doi: 10.4254/wjh.v13.i10.1439
Published online Oct 27, 2021. doi: 10.4254/wjh.v13.i10.1439
Table 2 One-, three-, and five-year survival analysis of patients with two hepatocellular carcinomas
| Overall survival (n = 104) | Overall survival | Overall survival | Transplanted survival (n = 25) | Transplant-free survival (n = 104) | Transplant-free survival | Transplant-free survival | |
| Synchronous group (n = 59) | Sequential group (n = 45) | Synchronous group (n = 59) | Sequential group (n = 45) | ||||
| 1-yr survival (%) | 93 | 91.3 | 95.3 | 100 | 77.1 | 68.5 | 93.2 |
| 3-yr survival (%) | 66.1 | 63.8 | 69.5 | 95.8 | 45.4 | 37.3 | 56.6 |
| 5-yr survival (%) | 62.3 | 61.1 | 64.6 | 95.8 | 37.8 | 29.7 | 48.5 |
- Citation: Pham AD, Vaz K, Ardalan ZS, Sinclair M, Apostolov R, Gardner S, Majeed A, Mishra G, Kam NM, Patwala K, Kutaiba N, Arachchi N, Bell S, Dev AT, Lubel JS, Nicoll AJ, Sood S, Kemp W, Roberts SK, Fink M, Testro AG, Angus PW, Gow PJ. Clinical outcomes of patients with two small hepatocellular carcinomas. World J Hepatol 2021; 13(10): 1439-1449
- URL: https://www.wjgnet.com/1948-5182/full/v13/i10/1439.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i10.1439